Toniolo 2017: Creatine for Bipolar Depression

Study Overview

Citation: Toniolo RA, Fernandes FBF, Silva M, Dias RS, Lafer B. (2017). Cognitive effects of creatine monohydrate adjunctive therapy in patients with bipolar depression: Results from a randomized, double-blind, placebo-controlled trial. Journal of Affective Disorders, 215, 108-113.

This randomised controlled trial examined creatine as an adjunct treatment for bipolar II depression — a condition characterised by depressive episodes alternating with hypomanic episodes. It is one of the first RCTs to examine creatine’s psychiatric applications.

Study Design and Methods

The study was a randomised, double-blind, placebo-controlled trial involving patients with bipolar II disorder in a depressive episode. Participants were already stabilised on mood stabiliser medication (lithium, valproate, or lamotrigine). They were randomly assigned to receive either 6g/day of creatine monohydrate or placebo for 6 weeks in addition to their existing medication.

Depression severity was measured using the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale (HDRS). Cognitive function was assessed using neuropsychological tests.

Key Findings

Depression Improvement

The creatine group showed significantly greater improvement in depression scores compared to placebo. MADRS scores improved meaningfully over the 6-week treatment period, suggesting that creatine augmentation has antidepressant potential in bipolar depression.

Cognitive Benefits

Participants in the creatine group also showed improvements in verbal fluency and other cognitive measures — consistent with creatine’s established role in brain energy metabolism.

Safety Profile

Creatine was well-tolerated with no serious adverse events. No cases of manic switching occurred during the study period, though the sample size was small and this remains a theoretical concern.

Important Caveats

1. Small sample size — Larger confirmatory trials are needed
2. Adjunct only — Creatine was added to existing medication, not used alone
3. Bipolar II only — Results may not generalise to bipolar I disorder
4. Short duration — 6 weeks may not capture long-term effects or risks
5. Manic switching risk — While not observed in this study, monitoring is essential
6. Not a treatment recommendation — This is preliminary research

Malaysian Relevance

Mental health treatment in Malaysia is evolving, with increasing access to psychiatric care. For Malaysian patients with bipolar depression already under psychiatric care, this research is worth discussing with their treating psychiatrist. Creatine supplementation should never be undertaken for psychiatric purposes without professional medical guidance.

Sources and References

• Toniolo RA, et al. (2017). Cognitive effects of creatine monohydrate adjunctive therapy in bipolar depression. JAD, 215, 108-113.
• Kreider RB, et al. (2017). ISSN position stand. JISSN, 14, 18.

Study Limitations

As with any individual study, several limitations should be considered when interpreting these findings:

• Sample size — many creatine studies use relatively small sample sizes, which can limit statistical power and generalizability
• Study population — results from young, trained males may not directly apply to women, older adults, or untrained individuals
• Duration — short-term studies may not capture long-term effects or the full trajectory of adaptation
• Dosing protocol — variations in loading and maintenance doses across studies make direct comparisons challenging
• Outcome measures — different studies use different performance tests, making meta-analytic comparisons complex

These limitations do not invalidate the findings but should be considered when applying them to individual supplementation decisions.

What This Means for You

For the average creatine user, this research supports the following practical recommendations:

1. Choose creatine monohydrate — it remains the most studied and effective form
2. Take 3-5g daily — consistent daily dosing is more important than timing
3. Take it with food — insulin response from meals enhances muscle uptake
4. Be patient — full saturation takes 3-4 weeks without loading
5. Combine with exercise — creatine works best when paired with resistance or high-intensity training

For more on practical dosing strategies, see our creatine dosage guide.

Study Design and Methodology

Understanding how a study was designed helps assess the strength of its conclusions. Key methodological factors to evaluate include:

• Sample size — larger studies (n=50+) provide more reliable results than small studies (n=10-15). Small sample sizes increase the risk of false positives and limit the ability to detect moderate effect sizes
• Study duration — creatine research requires adequate duration for muscle saturation (minimum 4 weeks for maintenance dosing, 1 week for loading). Studies shorter than this may miss the full effect
• Blinding — double-blind, placebo-controlled designs (where neither researchers nor participants know who receives creatine) are the gold standard for minimising bias
• Population studied — results from trained athletes may not fully apply to untrained individuals, and vice versa. Age, sex, and dietary habits (particularly vegetarian status) also influence creatine response
• Outcome measures — direct measures (muscle biopsy, MRS imaging) are more informative than indirect proxies (blood markers, performance tests) for assessing creatine uptake and metabolism

Clinical Implications and Practical Relevance

This research contributes to our understanding of creatine in several practical ways:

For athletes and fitness enthusiasts: The findings support the use of creatine monohydrate as a safe, effective ergogenic aid. The standard dosing protocol of 3-5g daily remains well-supported by the cumulative evidence base including this study.

For healthcare professionals: Understanding the specific mechanisms and safety data from studies like this helps clinicians provide evidence-based guidance to patients who ask about creatine supplementation. The research consistently shows a favourable safety profile at recommended doses.

For the Malaysian context: While most creatine research is conducted in Western populations, the fundamental biochemistry (ATP-phosphocreatine system) is universal. Malaysian consumers can apply these findings with confidence, adjusting for local factors like tropical climate (increased hydration needs) and halal dietary requirements (synthetic creatine monohydrate is permissible).

How This Fits Into the Broader Evidence

No single study should be used to make definitive claims about creatine supplementation. Instead, this research should be viewed as one piece of a much larger evidence base:

• The ISSN Position Stand (2017) synthesises hundreds of studies into comprehensive recommendations
• Multiple systematic reviews and meta-analyses confirm creatine’s effects on strength, power, and lean mass
• Long-term safety data spanning up to 5 years shows no adverse effects at recommended doses

For a complete overview of the evidence, explore our Research Library which covers 60+ landmark creatine studies.

Further Reading

• creatine dosage guide
• creatine safety profile
• creatine monohydrate
• creatine for brain health
• how creatine works
• buying creatine in Malaysia

Sources & References

Full citations available in our Research Library.